1. ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis
- Author
-
Daniela B.R. Leal, Viviane M. Bernardes, Jean L.G. da Silva, and Daniela F. Passos
- Subjects
0301 basic medicine ,Adenosine ,Immunology ,Arthritis ,Context (language use) ,Pharmacology ,GPI-Linked Proteins ,Arthritis, Rheumatoid ,03 medical and health sciences ,chemistry.chemical_compound ,Adenosine Triphosphate ,0302 clinical medicine ,Adenosine deaminase ,medicine ,Animals ,Humans ,Immunology and Allergy ,Receptor ,5'-Nucleotidase ,biology ,Apyrase ,Purinergic receptor ,medicine.disease ,Adenosine receptor ,030104 developmental biology ,chemistry ,biology.protein ,Receptors, Purinergic P2X7 ,Adenosine triphosphate ,Biomarkers ,Signal Transduction ,030215 immunology ,medicine.drug - Abstract
Rheumatoid arthritis (RA) is a classic inflammatory autoimmune disease. Local joint destruction and extra-articular manifestations of RA deeply compromise the life quality of the affected patients. RA immunopathogenesis depends on continuous immunogenic activation in which the purinergic system participates. The purinergic system comprises the signaling and metabolism of purines such as adenosine triphosphate (ATP) and adenosine. ATP signaling is involved in the activation and maintenance of the inflammatory state of RA through the activation of P2X7 and the production of cytokines, which orchestrate the pathogenesis of RA. The breakdown of ATP through the CD39/CD73 axis produces adenosine, which mostly inhibits the inflammatory process through activation of specific P1 receptors. Adenosine is hydrolyzed by adenosine deaminase (ADA) that interacts with other molecules playing additional roles in this disease. This review explores the release, metabolism, and the effects of binding of ATP and adenosine to their respective receptors in the context of RA, as well as their potential use as biomarkers and therapeutic targets.
- Published
- 2019
- Full Text
- View/download PDF